How to design and launch a successful Clinical Trial Manufacturing.

The COVID-19 pandemic demonstrated that the mass production of vaccines is crucial for our healthcare system. In order to ...

Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

Novartis invested €40 million (US$43 million) into the facility, which is the company’s first specialized viral vector manufacturing facility in ... and efficiency at all stages of the production ...

One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the lentiviral DNA payload, causing secondary cancers.

Comprehensive Analysis of Market Dynamics, Emerging Technologies, and ESG Trends Shaping the Future of Bioprocess Optimization and Digital Bio-manuf ...

Q4 2024 Earnings Conference Call April 9, 2025 8:00 AM ET. Company Participants. Frank Mathias - Chief Executive Officer Sebastien Ribault - Chi ...

Dr. Simone Steiner will focus on improving the manufacturing processes of individualized immunotherapies based on myvac® platform Strasbourg, ...

The points of the target shape on the right form a circular inner ring, as shown by the blue tracing. If you draw that exact circle on the SEM image on the right, you can see that PLDC created a ...

April 14, 2025 expert reaction to the Scunthorpe British Steel factory situation . Scientists comment on the British Steel factory situation. Prof David Dye, Professor of Metallur ...

The challenge today is not predicting what comes next; rather, it is keeping up with what is already happening. AI has moved ...

The discussion covered emerging biologics, AI applications, and a strategy for supporting biomanufacturing in the current political climate.